Literature DB >> 20033808

Post-surgical follow-up of colorectal cancer: role of contrast-enhanced CT colonography.

Emanuele Neri1, Paola Vagli, Francesca Turini, Francesca Cerri, Lorenzo Faggioni, Simone Angeli, Lorenzo Cini, Carlo Bartolozzi.   

Abstract

AIM: To evaluate the role of CT colonography (CTC) in the follow-up of patients having received partial colectomy for colorectal cancer. METHODS AND MATERIALS: CTC was performed in 72 subjects with history of partial colectomy for colorectal cancer. Colectomy had been performed in the right colon (n = 18), descending colon (n = 15), sigmoid colon (n = 21), and rectum (n = 18). Patients underwent CTC following incomplete conventional colonoscopy due to intolerance to endoscope insertion or luminal stenosis. In 70 cases pneumocolon was obtained through a rectal tube, and in 2 cases through a cutaneous anastomosis. CTC datasets were analyzed in combined 2D and 3D mode. All patients in whom CTC was suggestive for or raised the suspicion of disease recurrence underwent colonoscopy in sedation for confirmation of CTC findings.
RESULTS: CTC detected 7 cases of anastomotic stenosis. In 6/7 patients the stenosis was located in the sigmoid colon and in 1/7 patients at the level of the ileo-colic junction in the transverse colon. Out of these cases, four were fibrotic and three were neoplastic stenoses. In none of these cases was the CT appearance of the stenoses specific for disease recurrence, and conventional colonoscopy together with biopsy was necessary in order to characterize such findings. However, sensitivity of CTC in detecting anastomotic stenosis was 100% (7/7). One colonic mass (5 cm largest diameter) was detected in one case at the level of the proximal transverse colon in a patient with left colectomy performed 2 years before. The study of the residual colon showed 3 polyps in three patients (8, 6, and 5 mm, respectively). All CT findings were confirmed and characterized by conventional colonoscopy. In all cases the residual colon was entirely visualized by CTC with a completion rate of 100%.
CONCLUSIONS: CTC is a feasible and minimally invasive method for full exploration of the colon after surgical resection allowing detection of cancer recurrence, metachronous disease, and distant metastases in one single study, and represents a valid alternative to conventional colonoscopy in this patient population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20033808     DOI: 10.1007/s00261-009-9596-6

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  8 in total

Review 1.  Surveillance after curative treatment for colorectal cancer.

Authors:  Eric P van der Stok; Manon C W Spaander; Dirk J Grünhagen; Cornelis Verhoef; Ernst J Kuipers
Journal:  Nat Rev Clin Oncol       Date:  2016-12-20       Impact factor: 66.675

Review 2.  CT colonography for surveillance of patients with colorectal cancer: Systematic review and meta-analysis of diagnostic efficacy.

Authors:  François Porté; Mallikarjuna Uppara; George Malietzis; Omar Faiz; Steve Halligan; Thanos Athanasiou; David Burling
Journal:  Eur Radiol       Date:  2016-03-18       Impact factor: 5.315

3.  British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.

Authors:  Matthew D Rutter; James East; Colin J Rees; Neil Cripps; James Docherty; Sunil Dolwani; Philip V Kaye; Kevin J Monahan; Marco R Novelli; Andrew Plumb; Brian P Saunders; Siwan Thomas-Gibson; Damian J M Tolan; Sophie Whyte; Stewart Bonnington; Alison Scope; Ruth Wong; Barbara Hibbert; John Marsh; Billie Moores; Amanda Cross; Linda Sharp
Journal:  Gut       Date:  2019-11-27       Impact factor: 31.793

4.  Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline.

Authors:  Cristiano Spada; Jaap Stoker; Onofre Alarcon; Federico Barbaro; Davide Bellini; Michael Bretthauer; Margriet C De Haan; Jean-Marc Dumonceau; Monika Ferlitsch; Steve Halligan; Emma Helbren; Mikael Hellstrom; Ernst J Kuipers; Philippe Lefere; Thomas Mang; Emanuele Neri; Lucio Petruzziello; Andrew Plumb; Daniele Regge; Stuart A Taylor; Cesare Hassan; Andrea Laghi
Journal:  Eur Radiol       Date:  2015-02       Impact factor: 5.315

Review 5.  Imaging alternatives to colonoscopy: CT colonography and colon capsule. European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline - Update 2020.

Authors:  Cristiano Spada; Cesare Hassan; Davide Bellini; David Burling; Giovanni Cappello; Cristina Carretero; Evelien Dekker; Rami Eliakim; Margriet de Haan; Michal F Kaminski; Anastasios Koulaouzidis; Andrea Laghi; Philippe Lefere; Thomas Mang; Sebastian Manuel Milluzzo; Martina Morrin; Deirdre McNamara; Emanuele Neri; Silvia Pecere; Mathieu Pioche; Andrew Plumb; Emanuele Rondonotti; Manon Cw Spaander; Stuart Taylor; Ignacio Fernandez-Urien; Jeanin E van Hooft; Jaap Stoker; Daniele Regge
Journal:  Eur Radiol       Date:  2021-05       Impact factor: 5.315

6.  Transverse carcinoma after Miles operation: a case in which preoperative evaluation was assisted by computed tomographic colonography.

Authors:  Daisuke Ito; Masanori Teruya; Shojiro Hata; Kaoru Kobayashi; Michio Kaminishi
Journal:  World J Surg Oncol       Date:  2016-04-19       Impact factor: 2.754

Review 7.  Imaging the operated colon using water-enema multidetector CT, with emphasis on surgical anastomoses.

Authors:  Massimo Tonolini; Sonia Ippolito
Journal:  Insights Imaging       Date:  2018-04-09

8.  Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient Care.

Authors:  Perry J Pickhardt; Kristin Edwards; David H Bruining; Marc Gollub; Sonja Kupfer; Sam J Lubner; David H Kim; Eric Ross; Eileen Keenan; David S Weinberg
Journal:  Dis Colon Rectum       Date:  2017-11       Impact factor: 4.585

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.